Novartis AG (TSX:NVS)

Canada flag Canada · Delayed Price · Currency is CAD
24.68
0.00 (0.00%)
At close: Dec 1, 2025
10.23%
Market Cap 353.72B
Revenue (ttm) 78.52B
Net Income (ttm) 20.05B
Shares Out n/a
EPS (ttm) 10.17
PE Ratio 17.64
Forward PE 15.35
Dividend n/a
Ex-Dividend Date n/a
Volume 103
Average Volume 1,359
Open 24.68
Previous Close n/a
Day's Range 24.68 - 24.68
52-Week Range 20.11 - 25.84
Beta n/a
RSI 53.64
Earnings Date Feb 4, 2026

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy... [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 75,883
Stock Exchange Toronto Stock Exchange
Ticker Symbol NVS
Full Company Profile

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.